| Item Type | Name |
|
Concept
|
Alzheimer Disease
|
|
Academic Article
|
Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.
|
|
Academic Article
|
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
|
|
Academic Article
|
Chitin-like polysaccharides in Alzheimer's disease brains.
|
|
Academic Article
|
Untangling the vascular web from Alzheimer disease and oxidative stress.
|
|
Academic Article
|
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
|
|
Academic Article
|
Mark A. Smith: neurocytochemistry innovator.
|
|
Academic Article
|
Iron: the Redox-active center of oxidative stress in Alzheimer disease.
|
|
Academic Article
|
Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
|
|
Academic Article
|
Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease.
|
|
Academic Article
|
Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.
|
|
Academic Article
|
Prion disease and Alzheimer's disease: pathogenic overlap.
|
|
Academic Article
|
The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation.
|
|
Academic Article
|
Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease.
|
|
Academic Article
|
RNA oxidation in Alzheimer disease and related neurodegenerative disorders.
|
|
Academic Article
|
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.
|
|
Academic Article
|
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
|
|
Academic Article
|
Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease.
|
|
Academic Article
|
Frontiers in Alzheimer's disease therapeutics.
|
|
Academic Article
|
Increased expression of p130 in Alzheimer disease.
|
|
Academic Article
|
Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress.
|
|
Academic Article
|
Involvement of oxidative stress in Alzheimer disease.
|
|
Academic Article
|
Antioxidant approaches for the treatment of Alzheimer's disease.
|
|
Academic Article
|
Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
|
|
Academic Article
|
The role of novel chitin-like polysaccharides in Alzheimer disease.
|
|
Academic Article
|
Antimicrobial peptide ß-defensin-1 expression is upregulated in Alzheimer's brain.
|
|
Academic Article
|
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.
|
|
Academic Article
|
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules.
|
|
Academic Article
|
Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease.
|
|
Academic Article
|
Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-ß and Phosphorylated Tau.
|
|
Academic Article
|
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta.
|
|
Academic Article
|
Mark A. Smith, 1965-2010: consummate student of pathogenesis.
|
|
Academic Article
|
Oxidative damage in the olfactory system in Alzheimer's disease.
|
|
Academic Article
|
Oxidative stress and neurodegeneration.
|
|
Academic Article
|
Alzheimer disease pathology as a host response.
|
|
Academic Article
|
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.
|
|
Academic Article
|
Phosphorylated tau: toxic, protective, or none of the above.
|
|
Academic Article
|
Simultaneous onset of Alzheimer's disease in a husband and wife in their mid-fifties: what do we really know about environmental factors?
|
|
Academic Article
|
The role of iron as a mediator of oxidative stress in Alzheimer disease.
|
|
Academic Article
|
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
|
|
Academic Article
|
Widespread distribution of reticulon-3 in various neurodegenerative diseases.
|
|
Academic Article
|
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
|
|
Academic Article
|
Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease.
|
|
Academic Article
|
Iron: A Pathological Mediator of Alzheimer Disease?
|
|
Academic Article
|
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.
|
|
Academic Article
|
No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study.
|
|
Academic Article
|
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream.
|
|
Academic Article
|
Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease.
|
|
Academic Article
|
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.
|
|
Academic Article
|
Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches.
|
|
Academic Article
|
Mark A. Smith: the scientist, the man.
|
|
Academic Article
|
Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease?
|
|
Academic Article
|
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes.
|
|
Academic Article
|
Treatment advances in Alzheimer's disease based on the oxidative stress model.
|
|
Academic Article
|
Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.
|
|
Academic Article
|
Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease.
|
|
Academic Article
|
Current approaches in the treatment of Alzheimer's disease.
|
|
Academic Article
|
Cerebrovascular and mitochondrial abnormalities in Alzheimer's disease: a brief overview.
|
|
Academic Article
|
The complexities of the pathology-pathogenesis relationship in Alzheimer disease.
|
|
Academic Article
|
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
|
|
Academic Article
|
Role of mitochondrial dysfunction in Alzheimer's disease.
|
|
Academic Article
|
Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer's Disease.
|
|
Academic Article
|
Central role of brain regulatory T cells in the inflammatory cascade in Alzheimer's disease.
|
|
Academic Article
|
Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on a-Synuclein and Tau Aggregation.
|
|
Academic Article
|
Lessons from antiamyloid-ß immunotherapies in Alzheimer's disease.
|
|
Academic Article
|
Status and future directions of clinical trials in Alzheimer's disease.
|
|
Academic Article
|
Iron·ic facts about dementia.
|
|
Academic Article
|
High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease.
|
|
Academic Article
|
Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.
|
|
Academic Article
|
Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia.
|
|
Academic Article
|
Therapeutic Trials in Alzheimer's Disease: Where Are We Now?
|
|
Academic Article
|
The Amyloid Cascade Hypothesis: A Conclusion in Search of Support.
|
|
Academic Article
|
Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.
|
|
Academic Article
|
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.
|
|
Academic Article
|
Thermodynamics of Amyloid-ß Fibril Elongation: Atomistic Details of the Transition State.
|
|
Academic Article
|
Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
|
|
Academic Article
|
Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's disease.
|
|
Academic Article
|
Amyloid-ß peptide structure in aqueous solution varies with fragment size.
|
|
Academic Article
|
Hyperphosphorylated Tau Induces Cortical Hypoexcitability in Transgenic Mouse Models: A Meta-Analysis.
|
|
Academic Article
|
Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
|
|
Academic Article
|
Differences in structure and function between human and murine tau.
|
|
Academic Article
|
Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
|
|
Academic Article
|
Differential network analyses of Alzheimer's disease identify early events in Alzheimer's disease pathology.
|
|
Academic Article
|
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
|
|
Academic Article
|
Alzheimer's Disease: Not Just for the Aged?
|
|
Academic Article
|
Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.
|
|
Academic Article
|
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-ß Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
|
|
Academic Article
|
Antioxidant therapy in Alzheimer's disease: theory and practice.
|
|
Academic Article
|
Is US residence a risk factor for Alzheimer's disease?
|
|
Academic Article
|
Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria.
|
|
Academic Article
|
Synthesize heterogeneous biological knowledge via representation learning for Alzheimer's disease drug repurposing.
|
|
Academic Article
|
From Neurodegeneration to Brain Health: An Integrated Approach.
|
|
Academic Article
|
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry.
|
|
Academic Article
|
Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease.
|
|
Academic Article
|
The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease.
|
|
Academic Article
|
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease.
|
|
Academic Article
|
Making the Case for Accelerated Withdrawal of Aducanumab.
|
|
Academic Article
|
Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration.
|
|
Academic Article
|
Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders.
|
|
Academic Article
|
Modeling cholesterol metabolism by gene expression profiling in the hippocampus.
|
|
Academic Article
|
Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
|
|
Academic Article
|
The Microbiota-Gut-Brain Axis-Heart Shunt Part II: Prosaic Foods and the Brain-Heart Connection in Alzheimer Disease.
|
|
Academic Article
|
The Amyloid-ß Pathway in Alzheimer's Disease.
|
|
Academic Article
|
Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.
|
|
Academic Article
|
Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex.
|
|
Academic Article
|
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.
|
|
Academic Article
|
Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies.
|
|
Academic Article
|
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
|
|
Academic Article
|
Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer's disease brain.
|
|
Academic Article
|
Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains.
|
|
Academic Article
|
Precision pharmacology for Alzheimer's disease.
|
|
Academic Article
|
Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?
|
|
Academic Article
|
The structures of the E22? mutant-type amyloid-ß alloforms and the impact of E22? mutation on the structures of the wild-type amyloid-ß alloforms.
|
|
Academic Article
|
Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review.
|
|
Academic Article
|
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.
|
|
Academic Article
|
Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration.
|
|
Academic Article
|
Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
|
|
Academic Article
|
Microbes and Alzheimer's Disease.
|
|
Academic Article
|
Molecular Mapping Alzheimer's Disease: MALDI Imaging of Formalin-fixed, Paraffin-embedded Human Hippocampal Tissue.
|
|
Academic Article
|
Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
|
|
Academic Article
|
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization.
|
|
Academic Article
|
Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
|
|
Academic Article
|
Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aß by Using Several Synthetic and Herbal Compounds.
|
|
Academic Article
|
Hippocampal Unicellular Recordings and Hippocampal-dependent Innate Behaviors in an Adolescent Mouse Model of Alzheimer's disease.
|
|
Academic Article
|
SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders.
|
|
Academic Article
|
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
|
|
Academic Article
|
Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology.
|
|
Academic Article
|
Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease.
|
|
Academic Article
|
Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches.
|
|
Academic Article
|
BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways.
|
|
Academic Article
|
Assessment of X Chromosome Centromere Instability in Alzheimer's Disease: A Quantitative FISH Approach.
|
|
Academic Article
|
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model.
|
|
Academic Article
|
Conventional and Emerging Drug Targeting Sites in Alzheimer's Disease and the Role of Translational Informatics in its Diagnosis and Management.
|
|
Academic Article
|
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit.
|
|
Academic Article
|
Polyphenols in Alzheimer's Disease and in the Gut-Brain Axis.
|
|
Academic Article
|
Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective.
|
|
Academic Article
|
Posttranslational modifications of a-tubulin in alzheimer disease.
|
|
Academic Article
|
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks.
|
|
Academic Article
|
Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-ß and Phosphorylated Tau Proteins.
|
|
Academic Article
|
Fueling Alzheimer's Disease: Where Does Immunometabolism Stand?
|
|
Academic Article
|
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities.
|
|
Academic Article
|
Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
|
|
Academic Article
|
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
|
|
Academic Article
|
Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 2020.
|
|
Academic Article
|
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US.
|